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Patients with ileostomy typically have recurrent renal stones
and produce scanty, acidic, sodium-poor urine because of
abnormally large enteric losses of water and sodium
bicarbonate. Here we used a combination of intra-operative
digital photography and biopsy of the renal papilla and
cortex to measure changes associated with stone formation
in seven patients with ileostomy. Papillary deformity was
present in four patients and was associated with decreased
estimated glomerular filtration rates. All patients had
interstitial apatite plaque, as predicted from their generally
acid, low-volume urine. Two patients had stones attached
to plaque; however, all patients had crystal deposits that
plugged the ducts of Bellini and inner medullary collecting
ducts (IMCDs). Despite acid urine, all crystal deposits
contained apatite, and five patients had deposits of sodium
and ammonium acid urates. Stones were either uric acid or
calcium oxalate as predicted by supersaturation, however,
there was a general lack of supersaturation for calcium
phosphate as brushite, sodium, or ammonium acid urate
because of the overall low urine pH. This suggests that local
tubular pH exceeds that of bulk urine. Despite low urine pH,
patients with an ileostomy resemble those with obesity
bypass, in whom IMCD apatite crystal plugs are found. They
are, however, unlike these bypass patients in having
interstitial apatite plaque. IMCD plugging with sodium and
ammonium acid urate has not been found previously and
appears to correlate with formation of uric acid stones.
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Patients with ileostomy typically produce a scanty, acidic,
sodium-poor urine because of abnormally large enteric losses
of water and sodium alkali.1–3 As a result, they often develop
calcium oxalate (CaOx) and/or uric acid kidney stones,
although their urine calcium, uric acid, and oxalate
excretions are not themselves remarkably high.4 Sometimes,
renal function may decline because of renal uric acid
crystallizations, presumably when increased enteric fluid
losses reduce urine volume and pH; this is referred to as acute
uric acid nephropathy.5,6 To date, nothing has been published
regarding renal papillary tissue in patients with ileostomy
and recurrent renal stones; we present here our findings on
seven such patients.
These patients present an opportunity to test some
mechanisms suggested by our previous studies. The common
idiopathic CaOx stone former, who has no systemic disease
apart from familial (idiopathic) hypercalciuria, deposits
apatite plaque in the renal papillary interstitium, and stones
grow on papillary surfaces attached to sites of sub-urothelial
plaque.7,8 Interstitial apatite plaque abundance is propor-
tional to urine calcium excretion, and inverse to urine pH
and volume;9 hence, we might expect such plaque in
ileostomy patients even in the absence of hypercalciuria.
Patients with high urine volumes and pH, such as brushite
stone formers10 and those with renal tubular acidosis,11 do
not develop plaque, although they are hypercalciuric. Neither
do patients with obesity bypass and enteric hyperoxaluria;7
the latter have low urine pH but high urine volumes and low
urine calcium. Ileostomy or colostomy lower both urine
volume and pH thus plaque might occur, despite the lack of
hypercalciuria in these patients.
We have regularly found intra-tubular deposits of apatite
in patients who develop phosphate stones,10–12 not an
unexpected outcome given that such patients produce an
alkaline urine supersaturated with respect to phosphate
phases. Cystinuria also leads to such deposits,13 which are
found in tubules that are plugged with cystine. Perhaps
such local obstruction reduces local acidification leading to
an increase in calcium phosphate supersaturation; alkali
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treatment for prevention of cystine stones could also be a
factor. Hyperparathyroid stone disease produces both inter-
stitial plaque and intra-tubular deposits,12 which are reason-
able given sustained and severe hypercalciuria, which would
foster plaque, and a higher than usual urine pH, which would
foster tubule deposits. However, obesity bypass patients
present an anomaly in having tubule apatite deposits with an
acid urine pH, in which intra-tubular apatite would not be a
stable phase.7,14 For them, we have been forced to postulate
local tubular loss of acidification as we did for cystinuria.
In ileostomy or colostomy, we would expect interstitial
apatite plaque from low urine volume and pH, and uric acid
deposits in collecting ducts—because of low urine and
collecting duct fluid pH. In particular, we would not expect
apatite deposits to develop within collecting ducts, because
tubule fluid must have a low pH that corresponds to the low
pH of the final urine; low pH would not support apatite
formation. Therefore, in addition to presenting the tissue and
clinical results, we are interested in testing these two
reasonable predictions in order to clarify mechanisms for
plaque and tubule deposits.
RESULTS
Patients
Seven patients (three females) were studied (Table 1). All had
undergone ileostomy and total colectomy for ulcerative
colitis (five patients), Crohn’s disease (patient 2), and cancer
(patient 5). Stones were either CaOx or uric acid, and in one
subject (patient 6) both were formed. Age at ileostomy
ranged from 10 to 58 years, and the interval from ileostomy
to our study ranged from 3 to 41 years. Rates of procedures
varied from none to as many as 14, the present biopsy not
included.
Surgical anatomy and renal function
All seven patients displayed both white (interstitial apatite)
plaque (Figure 1a, c, and d, Table 2), and yellow (intra-
tubular crystal) plaque, which was not further quantified
(Figure 1a–d). The amounts of white plaque varied widely
(percentage of mean papillary surface area, Table 2). The
percentage of abnormal papillae varied among the patients
from 0 to 25% (papillary deformity, Table 2). Some papillae
with flattening and retraction also showed dilation of the
mouths of ducts of Bellini (BD) (Figure 1d), but dilation and
retraction were not well correlated (Table 2, Figure 1b and c).
Large crystal deposits were seen beneath the urothelium
filling tubular lumens (Figure 2a). Crystals occasionally
protrude from dilated BD openings (Figure 2b). On some
papillae in two patients (Table 2), CaOx stones were attached
to the papillary surface (Figure 2c) and at sites of white
Table 1 | Clinical characteristics and serum chemistries
Patient no. Sex
Age at
colectomy
(years)
Age at
first stone
(years)
Prior
stones
Age at
biopsy
(years) ESWL PNL
Total
procedures
Serum
creatinine
(mg/dl)
Serum CO2
(mM/l)
Serum
K (mM/l)
eGFR
(ml/min)
1 F 21 31 412/2 53 2/2 1/1 6/6 0.9 23 4.5 70
2 M 10 27 3/1 43 1/1 1/1 5/3 1.2 25 3.4 70
3 F 19 25 10/3 58 3/0 3/2 9/3 1 29 4.7 61
4 F 20 60 2 61 1 2 5 0.8 26 4.3 78w
5 M 58 59 8/6 61 1/0 2/1 5/2 2.3 19 5.2 31w
6 M 36 49 7/7 63 6/6 1/1 15/15 1.3 28 3.8 63
7 M 49 51 1 51 0 1/1 1/1 0.9 26 3.6 108
eGFR, estimated glomerular filtration rate; ESWL, extracorporeal shock wave lithotripsy; F, female; M, male; MDRD, Modification of Diet in Renal Disease; PNL, percutaneous
nephrolithotomy.
Prior stones: number of stones/number in the PNL kidney; total procedures: number procedures/procedures in the PNL kidney, including cystoscopy, open surgery,
ureteroscopy, as well as ESWL and PNL.
Patient 4 had a history of scleroderma, and patients 6 and 7 had diabetes. eGFR using MDRD equation.
wPatients with a previous history of acute renal failure.
Figure 1 | Endoscopic images of papilla from ileostomy
patients with kidney stones. Papillary morphology of ileostomy
patients ranged from a normal conical shape (a–c) to flattened
and retracted (d). Dilated openings (asterisks) to ducts of Bellini
were common in both the normal and deformed papillae (b–d).
Variable amounts of white (arrows) and yellow (arrowheads)
plaque were seen separately (d) or on the same papilla (a and c).
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plaque (Figure 2d–f). Unattached stones were found in all
patients, including these two.
Deformity of papillae (departure from a normal conical
smooth appearance) correlated roughly with the loss of
estimated glomerular filtration rate. The patient with the
most marked reduction of glomerular filtration rate (Table 1,
patient 5) had the highest percentage of abnormal papillae
(Table 2). Estimated glomerular filtration rate values of 61,
78, and 63 ml/min per 1.73 m2 were found in patients with
10% of papillae abnormal (Table 1 patient nos. 3, 4, and 6).
Those with no abnormal papillae had values of 70 or above. It
can be noted that episodes of acute renal failure had occurred
in two patients (Table 1, patient nos. 4 and 5). On the other
hand, we find a striking lack of correspondence between
amount of deposit and frequency of papillary deformity or
dilated ducts. Patient 4 (Table 2) with the most prominent
duct dilation had the most deposits, but only 10% of papillae
were deformed. Patient 1 had almost no inner medullary
collecting ducts (IMCDs) or BD deposits, and no deformed
papillae, but had moderate BD dilation; her deposits were
mainly in the cortex (Table 2). It can be noted that only one
patient (Table 2, patient 7) had deposits in the cortex, and he,
also, had no deformed papillae. Plaque and attached stones
also failed to correlate with each other or with laboratory
findings. One of the two patients with an attached CaOx
stone, one (Table 2, patient 7) had very extensive plaque and
the other (Table 2, patient 5) with an attached CaOx stone
had only modest amounts of plaque.
Although imperfect, we did find traces of our earlier
association of plaque with high urine calcium and low
urine pH and volume (Table 3). Patient nos. 2, 3, and 7 with
the most white plaque had very low pH (3 and 7) and/or
volume (2 and 3), and ample urine calcium. Patient 4,
with modest amounts of plaque, not only had low urine
calcium but also low volume and low pH. Patient 5, with very
modest amounts of plaque, had low urine calcium
and normal volume, and only low pH as a risk factor for
plaque. Patient 1, with the least plaque, had high urine
volume and low urine calcium but low urine pH. Patient 6 is
the one anomaly; hypercalciuria is marked, pH is low, and
volume is not remarkably high; however, plaque abundance is
only modest. Hence, with this one outstanding exception,
our patients followed the general pattern we have observed
in the past.
Table 2 | Surgical and pathological findings and stone type
Patient no.
Papillary
deformity (%)
% Mean papillary
surface area
Stones attached
to plaque Hydronephrosis
Dilated
BD
IMCD/BD
deposits
Cortical
deposits
Stone
type
1 0 0.5 No +++ ++ 1±1 Yes COM (1)
2 0 4.16 No + + 7±1* No UA (1)
3 10 5.16 No 0 ++ 15±2* No UA (1)
4 10 1.99 No 0 +++ 26±3* No UA (2)
5 25 1.34 Yes +++ + 8±1* No COM (2)
6 10 0.93 No 0 ++ 19±2* No UA + CA (6)
7 0 11.61 Yes 0 + 9±1 Yes COM (1)
CA, calcium; CaOx, calcium oxalate; CaP, calcium phosphate; COM, calcium oxalate monohydrate, IMCD/BD, inner medullary collecting duct/Bellini duct; UA, uric acid (number
analyzed).
% Papillary deformity refers to the fraction of papillae visualized at the time of surgery with deformity; % mean papillary surface area, percentage of papillary surface covered
by white plaque; stones attached to plaque, stones found attached to papilla on plaque at surgery; hydronephrosis, degree of renal pelvic dilatation at time of PNL, from
mild (+) to marked (+++); dilated BD, degree of dilatation of Bellini ducts; IMCD/BD, mean number of deposits per mm2 of tissue;
*Deposits that contained sodium acid urate and ammonium acid urate in addition to apatite; cortical deposits, crystal deposits found in cortical collecting ducts; stone type:
COM, UA; UA + CA, patient 6 had one pure UA stone, 2 stones with COM and UA, 2 stones with mixed CaOx and CaP, and 1 with CaOx, UA, and ammonium acid urate.
Figure 2 | Endoscopic images showing both intraluminal plugs
and attached stone in ileostomy patients. A dark region on the
papillary surface (a, arrow) marks a large intraluminal deposit deep
to the urothelium. The inset at the upper left corner of panel a
shows this same intraluminal deposit (arrow) by micro-computed
tomography (CT) in a biopsy sample removed at the site of the
deposit. Mineral plugs protruding from dilated ducts of Bellini (b,
arrowhead) were common. In addition, several stones were noted
attached to sites of Randall’s plaque. (c) Such a stone (double
arrows) can be seen. This stone was removed and photographed
by light microscopy (d and e) and scanned by micro-CT (f). The
papillary surface of this stone (e and f, double arrowheads) reveals
a whitish region that was determined to be hydroxyapatite by
micro-CT. Original magnification,  30 (d and e).
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When results from the present patients are plotted against
confidence ellipses from our original report of normal
subjects, CaOx stone formers, and patients with obesity
bypass, the fit for the multivariate score (Figure 3a) is not
unreasonable with one major outlier. For calcium and pH, all
of the results are at the left extreme of the ellipses; for
volume, points scatter within and outside the ellipse. This
represents, of course, the different mechanisms for plaque in
ileostomy: a much lower pH and calcium excretion, and
modestly lower volume, than in our original cases (Figure 3b).
Given especially the pH divergence, the predictive power of
our original ellipses is rather good. Of course, a score
calculated with the present data would tend to include the
present patients more completely.
Biopsy findings
Tubule deposits. With Yasue stain that highlights
calcium-based crystals, scattered tubules contained deposits
(Figure 4a–d) ranging from small to some large enough to
dilate and destroy tubules. Some deposits did not stain with
Yasue (Figure 4c), even though crystals were evident
microscopically. These Yasue-negative crystal deposits were
most prominent in BD (Figure 5a–c). Peritubular fibrosis was
more prominent around tubules containing the non-staining
vs the Yasue staining crystals. In two patients (Table 2),
Yasue-positive deposits were found in cortical collecting
ducts (Figure 5d). Some deposits were mixtures of Yasue-
positive and -negative crystals (Table 2). Overall, two
different kinds of crystals are found, calcium and non-
calcium based. Both were seen together in five of our
patients, but usually they were spatially separated, the
calcium deposits in more proximal IMCD segments, the
others mainly in distal IMCD and BD.
Nature of tubule and interstitial deposits. Interstitial plaque
was found in all patients, and stained positive with Yasue
stain (Figure 4d); using micro-Fourier transform infrared
(micro-FTIR) spectroscopy, we identified it as hydroxyapatite
plaque, identical to the Randall’s plaque we have found in
other patients. Yasue-positive intra-tubular deposits were also
identified as biological apatite (Figure 6), likewise identical to
deposits we have described previously. However, the non-
staining deposits most prominent in terminal BD were
identified as a mixture of sodium acid urate and ammonium
acid urate (Figure 6). A broad band at B1100 in the
spectrum of the non-Yasue-positive deposit is suggestive of
phosphate or sulfate. The presence or absence of uric acid
could not be determined from the infrared data; uric acid
does not display as distinctive a set of bands as do the sodium
and ammonium urate salts, and the few that do exist overlap
with spectral features of both other salts. Thus, we can state
that both sodium and ammonium acid urate salts are
present, but we cannot state that uric acid itself is not also
present.
Urine saturations, tubule deposits, and stones
Although all seven patients had intra-tubular apatite
deposits, urine was undersaturated with respect to calcium
phosphate (as brushite) in all but patient 2 (Table 3),
meaning that the precursors of intra-tubular apatite deposits
(brushite and octo-calcium phosphate) would not be a stable
phase in the bulk urine for any of the other patients.
Calculated supersaturation with respect to sodium acid urate
was below 1 in all but patients 3 and 6, despite deposits of
this phase in tubule lumens of five patients (Tables 2 and 3),
and supersaturation with respect to ammonium acid urate
was below 1 in all but patient 2. On the other hand, urine was
supersaturated with respect to uric acid in all but patient 1,
and highly supersaturated with respect to CaOx in patients 2,
3, 4, 6, and 7 (Table 3), so that the combinations of uric acid
and CaOx stones are reasonably easy to account for. We
cannot determine whether uric acid itself was present in any
of the tubule deposits. In other words, urine supersaturations
match closely with stone composition, but differ from
compositions of the tubule deposits.
DISCUSSION
Our patients mainly present the common and expected
clinical picture of ileostomy and stones. Stones are CaOx and
uric acid, a well-described feature.4,15 Urine is acidic in all
cases, and shows generally high uric acid and CaOx
supersaturations. These occur because of low volume and
pH for uric acid, and mainly low volume for CaOx. The one
overtly hypercalciuric patient had mixed CaOx–uric acid
stones, an expected result.
Interstitial apatite plaque was indeed present in all
patients, although prominent in only three (patients 2, 3,
Table 3 | 24-Hour urine results
Patient Vol pH CIT CA OX NA UA NH4 SUL SS UA SS CAOX SS CAP SS SAU SS AAU Wt (kg)
1 2.59 5.55 78 71 22 26 208 39 16 0.36 2.24 0.12 0.01 0.01 90
2 0.53 5.54 34 125 17 2 448 56 28 3.70 12.70 1.75 0.45 7.43 61
3 0.95 5.11 53 130 33 68 639 31 28 4.71 10.90 0.30 1.28 0.43 59
4 0.46 5.13 37 26 15 41 141 12 7 2.10 7.70 0.12 0.34 0.06 44
5 1.85 5.33 209 34 50 94 690 38 48 2.25 2.48 0.06 0.52 0.19 160
6 1.68 5.15 884 530 44 169 795 67 70 3.12 12.50 0.76 1.08 0.35 100
7 2.23 4.94 401 180 42 33 771 52 43 2.78 7.64 0.01 0.04 0.05 84
AAU, ammonium acid urate; CA, calcium, mg/d; CAOX, calcium oxalate; CAP, calcium phosphate; CIT, citrate, mg/d; NA, sodium, mEq/d; NH4, ammonium, mEq/d;
OX, oxalate, mg/d; SAU, sodium acid urate; SS, supersaturation; SUL, sulfate, mEq/d; UA, uric acid, mg/d; Vol, volume l/d.
Patients 3, 5, and 6 were taking potassium citrate, and patients 1 and 6 were taking allopurinol.
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and 7). Two patients had attached CaOx stones growing on
their papillae over regions of plaque similar to in the
idiopathic CaOx stone former. These findings confirm our
earlier ones in that low urine volume and pH would be
expected to cause plaque, and high urine supersaturations are
present to support CaOx overgrowths.
However, the intra-tubular deposits are not easy to
explain. All patients had IMCD apatite deposits, yet in six
of the seven patients urine was markedly undersaturated with
respect to calcium phosphate. This resembles our findings in
obesity bypass except that urine pH is even lower in these
patients and therefore the presence of universal tubular
apatite even more remarkable. The most reasonable assump-
tion is that local tubule fluid pH in some ducts departs
radically from that of the bulk urine pH, and is high enough
to make apatite a stable phase. We presume tubule cell injury,
perhaps from obstruction, crystals, or both have impaired
local acidification; this is pure speculation at this time.
This idea is supported by the other surprising finding: the
intra-tubular urate species encountered is not entirely uric
acid, which makes up the stones we found, but also include
sodium acid urate and ammonium acid urate, salts that are
stable when urine pH is high enough (B6) to assure
dissociation of a majority of uric acid. Urine from the
patients with urate deposits was, in all but two cases,
markedly undersaturated with respect to sodium acid urate.
For ammonium acid urate, supersaturation was present in
only one patient (patient 2, Table 3). Presumably, the same
local loss of normal tubule fluid acidification accounts for the
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Figure 3 |Comparison of present plaque data to our previous
reports. (a) Percentage of plaque coverage of renal papillae
gauged through intra-operative digital imaging (y axes of all four
panels) varied in our previous reports9 of normal, idiopathic
calcium stone formers and obesity bypass patients as in the
elliptical confidence bands shown on each panel. The present
seven patients are overplotted in gray symbols. In general, the
patients fall along or within the ellipses. (b) Compared with our
previous study cases, ileostomy patients have much lower pH as a
predominant cause of plaque, and moderately lower urine
volume and calcium excretion. Values are means.
Figure 4 |Histological images of Yasue-stained sections from
papillary biopsies from ileostomy patients. The morphology of
the papillary biopsies ranged from a normal architecture without
deposits (a) to an abnormal appearance characterized by
numerous dilated inner medullary collecting ducts and ducts of
Bellini filled with Yasue-positive (b–d, arrows) and Yasue-negative
deposits (panel c, double arrows) always associated with a loss of
lining cells (arrows) and surrounded by interstitial fibrosis. Sites of
interstitial plaque (Randall’s) were noted in the basement
membrane of thin loops of Henle (d, arrowheads). Original
magnification,  100 (a and b);  300 (c and d).
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multiple urate salt depositions and the apatite deposition.
Whether uric acid is also present is beyond the resolution of
the micro-FTIR methods we used. If it is or is not present,
however, the interpretation regarding intra-tubular pH
remains unchanged. In other words, the intra-tubular urate
we encountered is not compatible with bulk-phase urine
saturations, implying that conditions within tubules that
formed urate deposits must differ from those of the final
urine. On the other hand, formation of uric acid stones is
perfectly compatible with the final urine saturations.
Although urate salts and apatite occurred together in five
cases, the two crystals were spatially dissociated to some
extent. Urate was mainly in BD and distal IMCD, whereas
apatite was found only in IMCD. This is similar to cystinuria,
in which cystine plugs were mainly in BD and apatite in
IMCD. Perhaps, BD deposits obstruct IMCD, leading to the
loss of normal acidification that promotes apatite. However,
IMCD apatite also occurred without urate altogether.
Presumably because of the multiple crystallizations
in tubules, these patients, similar to those with brushite
nephropathy, renal tubular acidosis, cystinuria, and hyper-
parathyroidism, can have considerable papillary scarring
and retraction. Renal function, judged by estimated
glomerular filtration rate, can be reduced. Episodes of
acute renal failure were not rare, and probably were related
to volume depletion and crystallizations; these acute
injuries no doubt contributed to the tissue damage we
find.
We recognize that our study does not show how the uric
acid stones in patients 2–6 may have formed. None of the
large uric acid stones in these patients were attached
anywhere—they were free in the calyces or renal pelvis.
Perhaps, the tiny deposits in BD were originally uric acid, and
were extruded and served as a nidus for formation of
clinically significant uric acid stones. Uric acid stones were
probably formed in free solution in the calyceal or pelvic
Figure 5 |Histological images of tubules with Yasue-negative
deposits in inner medulla and Yasue-positive deposits in
cortex. (a and b) Each shows a large deposit in a duct of Bellini
(arrow) that is Yasue-negative except for a very small region of
Yasue-positive staining (double arrow). These plugged ducts are
generally very dilated, completely filled with mineral, surrounded
by interstitial fibrosis, and lack tubular lining cells. (c) Several
tubules filled with Yasue-negative deposits (arrows) are seen at
a higher magnification to show the loss of the tubular lining cells
(arrowheads). (d) Two cortical collecting ducts stained with Yasue-
positive deposits (arrows). Original magnification,  100 (a);
 200 (b);  300 (c); and  200 (d).
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Figure 6 |Micro-Fourier transform infrared (FTIR) spectra of
Yasue-negative and Yasue-positive crystal deposits in
ileostomy patients. This figure illustrates a series of infrared
spectra obtained for a set of standards (sodium acid urate (SAU),
uric acid (UA), ammonium acid urate (AAU), and hydroxyapatite),
for a site of a Yasue-positive deposit in the tissue, for a site of a
Yasue-negative deposit in the tissue, and for the normal tissue with
embedding medium. The infrared spectrum of the Yasue-negative
deposit is consistent with SAU and AAU: bands A, B, and D
highlighted by circles in the spectrum for the Yasue-negative
deposit correspond with bands a, b, and d, at wave numbers 3598,
1738, and 1257, respectively, in the spectrum for SAU. Band C in the
spectra for the Yasue-negative deposit (highlighted by a circle)
corresponds with band c at wave number 1385 in the spectrum for
AAU. A broad band at about 1100 (arrow) in the Yasue-negative
spectrum suggests phosphate or sulfate. The infrared spectrum of
the Yasue-positive deposit is consistent with hydroxyapatite as is
obvious by the matching of the large band at about 1000. Normal
tissue has no bands that correspond with those for the standards.
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urine. Possibly the tiny sodium acid urate and ammonium
acid urate BD deposits served as a nidus for uric acid stones.
MATERIALS AND METHODS
Clinical measurements
Two 24-h urine samples were collected while patients were eating
their free choice diet and off medications. In urine samples, we
measured volume, pH, calcium, oxalate, citrate, phosphate, uric
acid, sodium, potassium, magnesium, sulfate, and ammonia using
methods detailed elsewhere,16 and calculated supersaturation (SS)
with respect to CaOx, brushite, uric acid, sodium acid urate, and
ammonium acid urate using EQUIL 2.17 Routine clinical blood
measurements were performed on blood samples drawn for clinical
purposes.
Biopsy protocol and plaque area determination
During PNL, all papillae were digitally imaged as described
elsewhere.10 Biopsies were taken from one upper pole, inter-polar,
and lower pole papillum and from the cortex. Using the intra-
operative recordings,9 total surface area of each papilla was
measured, and one of us outlined areas of white (Randall’s)
plaque as well as the entire papilla on one set of prints. The white
plaque and total papillary areas were converted to numbers of
pixels, giving the ratio of plaque to total papillary pixels, or the
percentage of coverage with plaque. No biopsy site inspected
intra-operatively displayed significant hemorrhage and no post-
operative complications related to the biopsy procedures
occurred in any patient. The study was approved by the
Institutional Review Board Committee for Clarian Health
Partners (#98-073).
Tissue analysis
Light microscopy analysis. Twenty-four papillary and eight
cortical biopsy samples were studied using light microscopy. All
biopsy specimens were immersed in 5% paraformaldehyde in
0.1 mol/l phosphate buffer (pH 7.4) and were dehydrated through a
series of graded ethanol concentrations to 100% ethanol before
embedment in a 50:50 mixture of Paraplast Xtra (Fisher Scientific,
Itasca, IL, USA) and Peel-Away Micro-Cut (Polysciences Inc.,
Warrington, PA, USA). Serial sections were cut at 4 mm and stained
with the Yasue metal substitution method for calcium histochem-
istry,18 hematoxylin and eosin for routine histological examination.
An additional set of serial sections was cut at 7 mm for infrared
analysis.
Infrared analysis. Reflectance–absorption (R/A) spectra were
collected with a Perkin-Elmer Spotlight 400 infrared imaging
microscope interfaced to a Perkin-Elmer (Shelton, Connecticut,
USA) Spectrum One FTIR spectrometer. The system used a
100 m 100 m liquid nitrogen cooled mercury cadmium telluride
(HgCdTe) detector. Tissue samples were analyzed using an aperture
size appropriate to the size of the sample being studied (e.g.,
50–20 mm in diameter). Each spectrum collected represents the
average of 64 or 128 individual scans possessing a spectral resolution
of 4 cm1. A clean area on the low-E slide was used to collect the
background spectrum.
Attenuated total internal reflection spectra were collected for all
tissue samples with a Perkin-Elmer Spotlight 400 infrared imaging
microscope interfaced to a Perkin-Elmer Spectrum One FTIR
spectrometer. The system used a 100 m 100 m liquid nitrogen
cooled HgCdTe detector. The standard germanium internal reflec-
tion element was used in conjunction with a 100 mm 100mm or a
50 mm 50 mm aperture. As the attenuated total internal reflection
measurement is essentially an immersion measurement, the sampled
area using these apertures is 25 25 m or 12.5 12.5 m, respectively.
Each spectrum collected represents the average of 64 or 128
individual scans possessing a spectral resolution of 4 cm1. A clean
potassium chloride surface was used to collect the background
spectrum.
Two human kidney stones that were known to contain uric acid,
sodium acid urate, or ammonium acid urate as determined by
infrared analysis were used to collect control spectra for comparison
with spectra collected for tissue deposits. The infrared spectra
obtained from these kidney stones were validated by referencing the
previous work of Dao and Daudon.19
Micro-CT analysis. All papillary biopsies underwent micro-CT
analysis using the SkyScan-1072 (Aartselaar, Belgium) high-resolu-
tion desktop micro-CT system, allowing nondestructive mapping of
the location and size of the crystalline deposits within a biopsy
specimen. This micro-CT system can generate a tissue window so
that both the mineral deposit and tissue organization are seen at the
same time. For this protocol, biopsies are quickly dipped in a 1:10
dilution of Hypaque (50%, Nycomed, Princeton, NJ, USA)/
phosphate-buffered saline, then coated with a thin layer of paraffin
and mounted in the center of a small chuck, which is then locked
into place in the machine. The sample was positioned in the center of
the beam, and the system configuration was set at 35 kV, 209 mA,
1801 rotation, with flat-field correction. Images were saved to
compact disc and reconstructed with Cone-Reconstruction software
by SkyScan (Aartselaar, Belgium). These images were then recon-
structed into three-dimensional images with SkyScan’s CTAn þ
CTVol software. These images allowed us to properly orient each
biopsy for future light microscopic analysis. Three separate scans
from each patient were used to determine the number of sites of
intraluminal deposits per square millimeter, except for patient 5 in
which paraffin sections were used.
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